GlassScriptPhysician profile
Jonathan Ryan Winthers
NPI 1043643083
$737.62
in general payments reported to CMS, 2019-2025
10 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.42 · 2022: $13.70 · 2023: $113 · 2024: $379 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $158.28 | 2023-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $130.40 | 2024 | |
| Chiesi USA, INC. | $115.45 | 2024-2025 | Cleviprex, Kengreal |
| Boston Scientific Corporation | $81.55 | 2023-2025 | Watchman Access System, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.06 | 2023-2024 | Jardiance, Combivent Respimat |
| Pfizer INC. | $58.73 | 2024 | |
| Viatris Specialty LLC | $45.51 | 2025 | Yupelri |
| Lexicon Pharmaceuticals, INC. | $42.52 | 2023 | Inpefa |
| Vapotherm INC | $31.42 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Winthers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.